11:01
0
Jaguar Health Stock Surges 1585% on September 22 After FDA Fee Waivers
According to Quiver Quantitative, Jaguar Health (JAGX) shares surged as much as 1585.4% on September 22, 2026, closing the regular trading session up 1190.64% at $34.46, based on Benzinga data. The rally was driven by the FDA's announcement of fee waivers for the company's drugs Mytesi and Canalevia-CA1 for 2027, reducing near-term cash pressure. A 1-for-15 reverse stock split effective September 17, 2026, left Jaguar with approximately 520,088 shares outstanding, a thin float that amplified pri
More